Gene Therapy Technique May Allow Researchers to Suppress Abnormal Protein in Bone Disorder
Researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have taken the first preliminary steps for gene therapy of osteogenesis imperfecta (OI), a diverse group of disorders caused by various defects in type I collagen, a major component of bone.